Diagnostic Approach for Elevated Transaminases with Myopathy

Initial Evaluation

When a patient presents with elevated transaminases and myopathy, immediately check creatine kinase (CK) levels, as muscle injury—not liver disease—is the likely source of the transaminase elevation, and this distinction prevents unnecessary hepatic workup and diagnostic delays 1, 2
The essential first-line blood tests include creatine kinase (CK), which distinguishes muscle from liver pathology 1, 2, 3
Lactate dehydrogenase (LDH) can be elevated in muscle inflammation, and aldolase is an additional marker of muscle injury 1, 2, 3
Troponin is essential to evaluate for myocardial involvement, which can be life-threatening 1, 2, 3
Inflammatory markers (ESR and CRP) are used for monitoring disease activity 1, 2, 3

Perform a focused rheumatologic and neurologic examination that specifically evaluates muscle strength testing, skin examination, pattern of weakness, and respiratory muscle function 1, 2
Obtain cardiac testing immediately if there is any suspicion of myocardial involvement, as this represents a medical emergency requiring permanent discontinuation of any causative agents 1, 2, 3
Troponin levels, echocardiogram as needed, and additional cardiac testing based on clinical suspicion are crucial in cardiac evaluation 1, 2, 3

Consider electromyography (EMG), MRI of affected proximal limbs, muscle biopsy, paraneoplastic autoantibody testing, and autoimmune myositis panel when diagnosis is uncertain or to distinguish severity of phenotype 1, 2, 3
Rule out alternative causes of elevated transaminases with muscle symptoms, such as medication-induced, viral hepatitis, genetic myopathies, thyroid disorders, celiac disease, and hemolysis 1, 2, 5

Once diagnosis is established, monitor disease activity with serial CK levels, ESR, and CRP 1, 2, 3
Do not pursue extensive hepatic evaluation (including liver biopsy) in patients with elevated transaminases and any clinical evidence of muscle disease until CK has been checked, to prevent diagnostic delays and misdiagnosis of primary liver disease 4